Following in the footsteps of several pharma companies, life sciences giant Thermo Fisher is doubling down on investments at ...

OXB Named Among UK’s Best Employers by Financial Times in 2025Oxford, UK – OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, has been honoured with a spot on the ...

ViroCell manufactured a GMP lentiviral vector for UCL to accelerate research into prevention of relapse in childhood blood cancer UCL leveraged ViroCell’s expertise in lentiviral vector manufacturing ...

Ferring Pharmaceuticals announced today the U.S. Food and Drug Administration (FDA) approved a state-of-the-art drug product manufacturing hub in Parsippany, NJ, for its intravesical non-replicating ...

HCL AppScan API Security is designed to reduce security blind spots with an expert-trained, AI-infused discovery platform ...

HCLSoftware, a global leader in enterprise software solutions, announced today the launch of HCL AppScan API Security, in partnership with Salt Security. This comprehensive API security program ...

Dengue’s rise in 2024, influenced by climate change and shifting serotypes, underscores the need for effective vaccines to ...

Invenra Inc., a leader in multispecific antibody discovery and development, today announced the launch of its B-Body Express™ Antibody Expression service. This new offering enables biotechnology and ...

Pacira BioSciences, Inc.’s PCRX share price has surged by 5.48%, which has investors questioning if this is right time to ...

Ferring Pharmaceuticals presented the initial results from an ongoing Phase 3 trial (NCT05704244) in Japan assessing the efficacy and safety of ADSTILADRIN® (nadofaragene firadenovec-vncg) in patients ...